RAS Pathways in Prostate Cancer - Mediators of Hormone Resistance?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|8|834-839

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.8, 2010-12, pp. : 834-839

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 392-401

Bentham Science Publishers

Access to resources Recommend Favorite

The effect, moderators, and mediators of resistance and aerobic exercise on health-related quality of life in older long-term survivors of prostate cancer

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2821-2830

Blackwell Publishing

Access to resources Recommend Favorite

Agonists of luteinizing hormone-releasing hormone in prostate cancer

By Rick Ferenc G   Block Norman L   Schally Andrew V  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2237-2247

Informa Healthcare

Access to resources Recommend Favorite

Novel Targeting of Apoptosis Pathways for Prostate Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 1, 2004-02 ,pp. : 85-95

Bentham Science Publishers

Access to resources Recommend Favorite

Which drug combination for hormone-refractory prostate cancer?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 667-670

Informa Healthcare

Access to resources Recommend Favorite